7P4S
BROMODOMAIN OF HUMAN TAF1 (2) WITH naphthyridinone compound
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID23-1 |
Synchrotron site | ESRF |
Beamline | ID23-1 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2015-02-23 |
Detector | DECTRIS PILATUS3 2M |
Wavelength(s) | 0.976 |
Spacegroup name | P 21 21 2 |
Unit cell lengths | 54.651, 56.007, 58.308 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 32.480 - 2.170 |
R-factor | 0.2049 |
Rwork | 0.202 |
R-free | 0.27360 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3uv4 |
RMSD bond length | 0.010 |
RMSD bond angle | 1.010 |
Data reduction software | XDS |
Data scaling software | Aimless |
Refinement software | BUSTER (2.11.6) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 56.010 | 2.430 |
High resolution limit [Å] | 2.170 | 2.170 |
Rmerge | 0.118 | 0.616 |
Number of reflections | 9952 | 2763 |
<I/σ(I)> | 8.9 | 2.9 |
Completeness [%] | 99.9 | 99.9 |
Redundancy | 6.3 | 6.5 |
CC(1/2) | 0.994 | 0.945 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 278 | 30% w/v EDO_P8K, 0.1M Morpheus buffer 2 and 10% morpheus alcohols |